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Understanding the genetic basis for a phenotype is a central goal in biological research. Much has been learnt about bacte-
rial genomes by creating large mutant libraries and looking for conditionally important genes. However, current genome-
wide methods are largely unable to assay essential genes which are not amenable to disruption. To overcome this limitation,
we developed a new version of “TraDIS” (transposon directed insertion-site sequencing) that we term “TraDIS-Xpress” that
combines an inducible promoter into the transposon cassette. This allows controlled overexpression and repression of all
genes owing to saturation of inserts adjacent to all open reading frames as well as conventional inactivation. We applied
TraDIS-Xpress to identify responses to the biocide triclosan across a range of concentrations. Triclosan is endemic in modern
life, but there is uncertainty about its mode of action with a concentration-dependent switch from bacteriostatic to bacter-
icidal action unexplained. Our results show a concentration-dependent response to triclosan with different genes important
in survival between static and cidal exposures. These genes include those previously reported to have a role in triclosan re-
sistance as well as a new set of genes, including essential genes. Novel genes identified as being sensitive to triclosan exposure
include those involved in barrier function, small molecule uptake, and integrity of transcription and translation. We antic-
ipate the approach we show here, by allowing comparisons across multiple experimental conditions of TraDIS data, and
including essential genes, will be a starting point for future work examining how different drug conditions impact bacterial
survival mechanisms.
[Supplemental material is available for this article.]
Triclosan is a broad-spectrum antimicrobial that was first devel-
oped in the 1960s. Since then, it has been used extensively in a
wide range of products for clinical, veterinary, and domestic use
(Yazdankhah et al. 2006), such as hand soaps, mouthwashes,
toothpaste, shampoos, and cosmetics, as well as being incorporat-
ed into plastics. Triclosan acts by inhibiting type II fatty acid bio-
synthesis and is the archetypal inhibitor of this essential
pathway in bacteria. Over the years, other compounds that inhibit
enzymes in this pathway have progressed to different stages of
clinical development as novel antibiotics, but triclosan is the
only one in widespread domestic use. Triclosan specifically inhib-
its the enzyme FabI; an enoyl-acyl carrier protein (ACP) reductase
conserved across bacteria; hence, triclosan has a correspondingly
broad spectrum of activity against most bacteria (Russell 2004).
The use of triclosanhas proliferated to such an extent that it is
readily identified in most aquatic environments and is detectable
in the urine and blood plasma of most people in the developed
world, where use has been extensive in personal care products, par-
ticularly toothpastes (Toms et al. 2011; Mathews et al. 2014;
Savage et al. 2014). A U.S. study found ∼10% of adults had levels
of triclosan in their urine above the minimum inhibitory concen-
tration required to inhibit most bacteria (Calafat et al. 2008).
There has been pressure to ban triclosan use owing to con-
cerns about its potential impact as a hormone-disrupting agent
and evidence that exposure to triclosan can select for mutants
cross-resistant to antibiotics (Webber et al. 2013; Li et al. 2019;
Westfall et al. 2019). Evidence from mouse studies has suggested
that triclosan exposure can alter the composition of the gutmicro-
biota and may induce inflammation and promote colonic cancers
(Yang et al. 2018). The impact of triclosan in urban (built) environ-
ments, where it is now a common contaminant in developed
countries (Fahimipour et al. 2018), has recently been investigated.
Correlations between triclosan concentrations and organisms pre-
sent in dust strongly suggest the selection of drug-resistant bacte-
rial communities in the presence of triclosan (Fahimipour et al.
2018).
Although the primary target of triclosan has been established
as FabI, a full understanding of triclosanmechanisms of action has
remained elusive. It has been shown that triclosan exerts a bacter-
iostatic effect at low concentrations (McMurry et al. 1998b) but, at
higher concentrations, is bactericidal (McMurry et al. 1998b).
Triclosan resistance also appears multifactorial; highly resistant
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mutants typically have substitutions within FabI that reduce bind-
ing efficiency of triclosan, but multidrug efflux pumps, barrier
function, changes to fabI expression, core metabolic pathways
and sigma factor–controlled stress responses have all been impli-
cated as being involved in triclosan resistance (McMurry et al.
1998a; Webber et al. 2008a,b; Bailey et al. 2009; Gantzhorn et al.
2015). A specific link between resistance to fluoroquinolone anti-
biotics and triclosan, mediated by altered stress responses present
in gyrA mutants, has also recently been described (Webber et al.
2013).
Given renewed interest in the impact of triclosan on popula-
tion health and themicrobiome, we felt it was timely to systemati-
cally investigate the mechanisms of action and resistance of
triclosan across a range spanning bacteriostatic and bactericidal
concentrations. This will help understanding of the potential im-
pacts and risks of exposure to triclosan under different conditions
as well as informing fatty acid inhibitor development programs
and providing further insight into the impacts of triclosan on
the microbiome.
Previous systems biology approaches to investigate bacterial
responses to triclosan have focused on nucleotide sequencing
the genomes of mutants or on transcriptomic and proteomic anal-
ysis that have tended to use a small number of concentrations
(Webber et al. 2008a; Bailey et al. 2009). These studies have been
informative, although each is limited to providing a snapshot of
genes potentially involved in triclosan susceptibility at one
condition.
Here we applied a modified version of “TraDIS” (transposon
directed insertion-site sequencing) (Langridge et al. 2009;
Barquist et al. 2016) to identify genes involved in sensitivity to tri-
closan over a wide range of concentrations. TraDIS, or other anal-
ogous approaches relying in high-throughput sequencing of
transposon mutant libraries such as Tn-seq or HITS (van Opijnen
and Camilli 2013), combines production of a large, saturating
transposon mutant library with sequencing of all transposon–
chromosome insertion junction sites in parallel. Differences in
insertion sites when grown in different conditions identify genes
involved in survival of any given test condition. However, tradi-
tional TraDIS protocols have been limited by being unable to assay
essential genes that do not tolerate any insertions within them, as
well as by being costly and generating large volumes of data, which
are difficult to analyze. Our new methodology uses a transposon
with an outward-directed inducible promoter, allowing the impact
of gene overexpression and gene silencing of every gene in a
candidate organism to be assayed (in addition to insertional
inactivation), and we refer to this approach as TraDIS-Xpress. By
using TraDIS-Xpress, we analyzed the response of Escherichia coli
to triclosan at eight concentrations spanning a 125-fold range.
We also used a refined analysis pipeline we have developed
(AlbaTraDIS) to identify and compare changes in insertion site
abundance from multiple exposure conditions, as well as to auto-
matically predict impacts of insertions on gene function and
expression.
By using this approach, we show distinct concentration-de-
pendent responses to triclosan and identify novel genes involved
in triclosan susceptibility, including the identification of potential
routes of entry into the cell. We were also able to systematically
document different impacts on distinct sets of genes between ex-
posure to bacteriostatic and bactericidal concentrations of the
drug for the first time. The ability to regulate expression of all
the genes of a target organism in one massively parallel experi-
ment in a controlled manner promises to be a hugely powerful
strategy that has the potential to uncover new genotype–pheno-
type relationships.
Results
Creation of a high-density transposon insert library
in E. coli strain BW25113
E. coli BW25113 was transformed with a bespoke Tn5-based trans-
poson containing an outward facing tac promoter. To confirm that
a suitable number of unique transposon inserts had been harvest-
ed and that the modified TraDIS-Xpress sequencing strategy
worked, DNA was extracted from the transposon mutant library
pool and was processed for TraDIS sequencing (Supplemental
Fig. S1). In this experiment, 5.1 million TraDIS reads were mapped
to the BW25113 reference genome at 813,873 unique sites, giving
an average of one insertion site every 6 bp (Supplemental Fig. S2).
Analysis of the insertion sites revealed an expected lack of inserts
in genes previously reported as essential (Goodall et al. 2018).
These data confirmed that a high-density mutant library covering
the genome had been created and that the modified TraDIS se-
quencing method worked as expected. We also assessed the repro-
ducibility of experiments by comparing data from two separate
cultures seeded from the library by sequencing transposon inser-
tion sites in control conditions and in the presence of three con-
centrations of triclosan (Supplemental Fig. S2). These data
showed excellent correlation between the replicates. Finally, 48 in-
dividual transposon mutants were randomly selected and whole-
genome-sequenced to check insertion sites. Bioinformatic analysis
of these mutants confirmed that each mutant contained only one
copy of the transposon inserted in the genome at unique posi-
tions, thus supporting the assertion that the transposonmutant li-
brary pool consists largely of mutants with single transposon
insertions.
A key advantage of TraDIS-Xpress is the use of an inducible
promoter that allows expression changes to be inferred and gives
the ability to score essential genes for involvement in a phenotype.
To assess the utility of promoter induction, we determined the
number of loci reported as involved in triclosan susceptibility in
each condition in the presence and absence of induction
(Supplemental Fig. S3). These data revealed additional information
was retrieved for seven of the eight test conditions, with an average
of 21% more targets being identified when induction of the out-
ward facing promoter was applied.
TraDIS-Xpress is a powerful tool that identifies multiple genes
involved in triclosan sensitivity
A total of 66 independent TraDIS experiments were completed
across a 125-fold concentration range of triclosan. Analysis of
the differential abundance of insertion sites in the presence of tri-
closan identified previously reported mechanisms of triclosan re-
sistance as highly significant targets. FabI is the product of the
essential gene fabI, which cannot be inactivated by transposon in-
sertion. Our data (Fig. 1) revealed a highly significant enrichment
of transposon inserts upstream of fabI in triclosan-treated experi-
ments (these were present upon the addition of IPTG but not in
uninduced conditions) with a very strong bias for transposon in-
sertions oriented such that the outward directed promoter will
up-regulate transcription of fabI. This confirmed that we were




shows that TraDIS-Xpress can readily identify the contribution of
an essential gene to survival following exposure to a target drug.
Comparison of results from libraries exposed to triclosan in
the presence of IPTG with those without addition of inducer
clearly showed the enrichment of insert sites upstream of and
downstream from genes in the presence of the inducer (Fig. 1).
This included various essential genes in which overexpression or
repression owing to antisense insertion sites was enriched by tri-
closan exposure only in the presence of inducer. These data con-
firmed that TraDIS-Xpress was able to efficiently assay the roles
of essential genes in triclosan sensitivity and that therewas not sig-
nificant “leakiness” of the outward facing promoter without
induction.
Multidrug efflux pumps and outer membrane porins have
also been shown previously to influence triclosan sensitivity, in-
cluding the multidrug efflux system AcrAB. Mutants with inserts
within the genes encoding the structural components of this
pump were depleted in the presence of triclosan concentrations
above the MIC (Fig. 1), whereas inserts within the local repressor
of the system, acrR, were enriched. Similarly, mutants within outer
membrane porin, ompF, were enriched in the presence of triclosan.
Expression of acrAB and ompF are controlled by global stress re-
sponse systems, marRA and soxRS; inserts within marR and soxR
(both of which result in derepression of the cognate transcription-
al activator genes,which then promote pump expression)were sig-
nificantly enriched upon triclosan exposure. Inactivation of sigma
factors has also been associated previouslywith triclosan resistance
(Gantzhorn et al. 2015); in our data, there was significant enrich-
ment of inserts immediately downstream from rpoN (Fig. 1) but in
an antisense orientation in the presence of triclosan, showing that
inducible promoters can also identify genes in which repression is
beneficial following exposure to a given stress. Reducing expres-
sion of rpoN is likely to alter the cell re-
sponse to stress, although the direct
impact of individual effectors on triclo-
san sensitivity is unclear.
To assess the validity of predictions
made by TraDIS-Xpress, we selected 78
mutants from the Keio collection in
which altered sensitivity to triclosan
was predicted, three randomly selected
mutants from the collection, and a set
of other importers. We modelled growth
and compared eachmutant to the parent
and assessed how the fitness score from
AlbaTraDIS related to growth ability in
the presence of triclosan. Supplemental
Figure S4 shows how each mutation af-
fected the ratio of growth with no anti-
microbial with growth in 0.125 mg/L
triclosan, compared to the same ratio in
BW25113. This shows that, on average,
mutants followed the prediction by
TraDIS-Xpress, with the majority show-
ing less sensitivity to triclosan than the
wild type and a smaller set (including
the expected effluxmutants) showing in-
creased sensitivity. The random mutants
not indicated by TraDIS did not show
any detectable change in their suscepti-
bility. Comparisons of the AUC values
showed most mutants followed the pre-
dicted impacts; 92% of the mutants showed a change in AUC
>20% ± the parent strain in line with the prediction made by
TraDIS-Xpress, although the statistical power of this comparison
is weak for any individual mutant. Supplemental Figure S5 shows
the relationship between TraDIS-Xpress fitness scores with these
growth data (both in the presence of 0.125 mg/L of triclosan), al-
though those mutants with the clearest positive and negative sig-
nals from TraDIS-Xpress have clear corresponding effects seen in
growth experiments. There is, however, little evidence of a general
correlation between the strength of a TraDIS-Xpress log fold chan-
ge and corresponding growth ability.
Concentration-dependent results of exposure to triclosan
are clearly revealed
Although the well-established mechanisms of triclosan resistance
were identified in our data, there were also many genes identified
that have not previously been implicated in triclosan resistance.
The genes identified were concentration dependent, and exposure
to different concentrations of triclosan resulted in a range of im-
pacts on cellular viability (Fig. 2).
Similarly, distinct patterns of transposon mutants were re-
vealed across the range of drug exposures. Twomajor groups of re-
sponses were evident from analysis of the data; one block of genes
was selected by exposure to concentrations of triclosan at the MIC
and below, and another block was selected by exposure to concen-
trations above the MIC (Table 1; Fig. 2; Supplemental Table 1).
Genes involved in fimbriae biosynthesis ( fimABCDEI) were select-
ed across a wide range of concentrations.
The “MIC and below” block was characterized by the protec-
tion of genes encoding lipopolysaccharide biosynthesis, purine
biosynthesis, and methionine biosynthesis. Inactivation of marR,
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Figure 1. Validation of TraDIS-Xpress. Identification of known targets using the TraDIS-Xpress ap-
proach incorporating an inducible outward-facing promoter that identifies the impact of both essential
and nonessential genes on survival and growth. (A) Geneticmap of the relative gene positions is shown at
the bottom of the panel. Above this, each row of vertical red or blue lines (plotted with red behind) indi-
cates the position of mapped reads, and the height of the bar represents the relative number of reads
mapped. Red indicates transposon insertions wherein the transposon-encoded kanamycin-resistance
gene is oriented 5′ to 3′ left to right, and blue indicates the opposite right-to-left orientation. (A,B)
Data split with induced and uninduced libraries shown at a single concentration of triclosan; this makes
the impact of induction obvious. (C,D) Results from different drug concentrations (all with induction).
(A) Inserts predicted to result in up-regulation of fabI in the presence of triclosan. (B) Mutants up-regu-
lating skp, lpxD, fabZ, lpxA, and lpxB. (C) Mutants inactivating acrR and up-regulating acrAB being en-
riched by triclosan. (D) Mutants positioned antisense to rpoN being selected in the presence of
triclosan. The top row in each plot shows untreated control cultures; the three rows below are for cultures





the repressor of the global stress response regulator,marA, was also
selected in this block.
The “above MIC” block included mutants that result in dere-
pression of the global stress regulator, soxS, which (as with marA)
controls expression of acrAB and repression of the major porin,
ompF. Together, these will result in reduced permeability of the
cell to triclosan (Blair et al. 2014). This block also identified protec-
tion of the structural components of the AcrAB multidrug efflux
system and overexpression of another ef-
flux system, EmrAB. In addition, inacti-
vation of the ribose uptake system
RbsACB and potassium uptake transport-
er TrkAH was also predicted to be protec-
tive of exposure to triclosan. Other loci
identified as contributing to survival at
the highest concentrations of triclosan
included fatty acid biosynthetic genes
(including fabI), the phospholipid recy-
cling pathway (mlaBCDEF), ubiquitins
(ubiDEFGHL), and rpoN. Additionally, a
set of genes all involved in the stability
of mRNA, proteins, and translation initi-
ation (pcnB, infB, lon, and rsmB) was also
identified as contributing to survival at
high triclosan concentrations (Table 1).
Triclosan sensitivity is impacted by
ribose and potassium import systems
Although triclosan has a validated intra-
cellular target in FabI, it is currently un-
clear how it crosses the cytoplasmic
membrane. TraDIS data identified inacti-
vation of rbsB, the periplasmic ribose
binding domain of the RbsABC ribose
importer and trkHA, components of a po-
tassium importer as being beneficial to
survival in the presence of triclosan.
Defined rbsB, trkH, or trkA mutants
from the Keio mutant collection showed
significantly (P<0.01) better growth
comparedwith BW25113 in the presence
of 0.125 mg/L of triclosan, although
none were able to grow at 0.5 mg/L (Fig.
3). These data support the hypothesis
that these transporters are involved in tri-
closan sensitivity.
Genes maintaining transcript and
protein stability are involved in triclosan
sensitivity
The mechanism by which triclosan
exerts a bactericidal effect at high con-
centrations is not understood. TraDIS-
Xpress identified a set of genes that are
involved in mRNA stability, initiation
of translation, and protein stability as be-
ing relevant to survival in the presence of
high concentrations of triclosan. These
included pcnB, which adds poly(A) tails
to newly synthesized mRNA transcripts,
which target their digestion; inactivation
of pcnB gave a selective advantage during growth in triclosan (Fig.
4). TraDIS-Xpress also identified a selective advantage in triclosan
for mutants with insertions immediately upstream of both infB
and rsmB, which code for a translation initiation factor and a
methyltransferase acting to stabilize binding of initiator tRNAs
to the ribosome preinitiation complex, respectively. Finally, mu-
tants with inactivation of the Lon protease were found to survive
better in the presence of triclosan (Fig. 4). Lon is a general protease
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Figure 2. Dose-dependent activity of triclosan. (A) Viability of BW25113 from LB broth cultures supple-
mented with different concentrations of triclosan, immediately after inoculation (top) and after incuba-
tion for 24 h (bottom). Samples from the cultures were serially diluted 10-fold, and 5 µL of all dilutions was
spotted onto LB agar and incubated. The level of dilution (from10−1 to 10−7) is shown on the right side of
the photographs, and the concentrations of triclosan in the cultures are shown along the top. The results
show a bactericidal effect >0.5 mg/L; triclosan at 0.25 mg/L caused a 10-fold reduction in growth over
the 24-h period, but at ≤0.125 mg/L, there was no growth inhibition. (B) Heat map highlighting differ-
ences in reads mapped to genes at the different triclosan concentrations shown along the bottom of the
chart. Each row represents a gene, and genes are ordered from top to bottom. The intensity scale reflect-
ing the size of difference is shown on the right of the map. (C ) Network produced by the AlbaTraDIS soft-
ware illustrating the genes identified as important at different concentrations of triclosan. Nodes
represent genes (blue) or triclosan concentrations (indicated by colored nodes); edges show links be-





(previously implicated in processing of AcrB). These observations
suggest that exposure to higher triclosan concentrations impairs
mRNA transcript stability and protein translation; thus, mutations
that result in increased stability of mRNA and proteins provide a
selective advantage.
Modulating expression of triclosan sensitivity genes confirmed
predictions about the impacts of specific genes on survival in the
presence of triclosan
A key advantage of using promoters in transposonmutant libraries
is the ability to assay essential genes that cannot be inactivated for
roles in stress responses. TraDIS-Xpress identified numerous genes
in which the pattern of transposon inserts suggested expression
changes were altering triclosan sensitivity. For some of these
genes, a growth advantage with triclosan was predicted owing to
transposon insertions downstream from the gene and to the pro-
duction of an antisense transcript that will interfere with transla-
tion of mRNA. To verify these predictions, a selection of these
genes was chosen for artificial up- or down-regulation. A series of
constructs were made in the pBAD gene expression vector (Fig.
5), with some inserted in reverse orientation to mimic observa-
tions from the TraDIS-Xpress data. None of the E. coli derivatives
harboring these plasmid constructs showed any change in growth
rate on triclosan-free media. After induction with arabinose, con-
structs overexpressing fabI, infB, andmarA showed consistent “res-
cue” of the ability to grow in the presence of 0.5 mg/L on agar.
Constructs overexpressing fabA, or antisense to rpoN and pstA,
showed rescue of growth ability in the presence of triclosan in
broth (consistently showing an ability to grow in concentrations
of triclosan one or two dilutions higher than the parent), although
this was not reproduced when grown on agar. The original TraDIS-
Xpress experiments were completed in broth, and these genesmay
have inherently different baseline levels of expression when cells
are grown on a solid medium, which may explain this mismatch.
Artificial overexpression of fabZ appeared to be consistently lethal.
Vector-only controls or a clone containing lacA (chosen as a ran-
dom gene not implicated in triclosan sensitivity) showed no phe-
notype, as expected (Fig. 5).
Discussion
The use of large transposon libraries and massively parallel se-
quencing to assay the fitness of large numbers of mutants has
proved powerful in defining the essential set of genes needed for
anybacteria togrow inanyspecific condition. Forexample, a recent
report refined the E. coli essential gene list in common laboratory
conditions and identified essential regions within genes (Goodall
et al. 2018). Studies using the original TraDIS methodology are,
however, limited by not being able to assay essential genes and
by the time taken to make mutant libraries and sequencing costs,
which are high as “diversity” samples often need to be added to
the flow cell if using an Illumina sequencing instrument, reducing
the amount of data that can be produced from the experimental
samples per run. Improved workflows included the use of out-
ward-facing promoters of different strengths have helped to ad-
dress this shortcoming, and the cost per typical TraDIS-Xpress
experiment has now been reduced significantly compared with a
corresponding experiment with the original TraDIS workflow.
Cost savings result from use of conjugative plasmids to deliver
transposons in library construction rather than multiple rounds
of laborious electroporation, sequencing primers that are included
making the workflow compatible with standard Illumina library
preparation and sequencing protocols and improved bioinfor-
matics. All these reduce hands-on time significantly, and our
currentworkflows are approximately threefold cheaper in consum-
ables costs and approximately fivefold faster than conventional
protocols. Supplemental Table 2 summarizes time and cost savings
with TraDIS Xpress compared with the original TraDIS approach.
Other methods to assay the role of all known genes within a
bacterium in a phenotype of interest have been attempted, includ-
ing the recent application of CRISPRi (Lee et al. 2019) in which
genes are silenced, although this requires prior knowledge of genes
to target and cannot assess the impact of gene overexpression on a
phenotype, or mutation, of intergenic regions. Our method also
provides much greater resolution; we introduced an average of ap-
proximately 125 inserts into each gene, allowing the essentiality of
domains encoded by parts of a gene to be tested rather than single
knockdown of a gene.We also assay all the noncoding parts of the
genome in this approach.
Table 1. Selected pathways involved in triclosan sensitivity at different conditions
Loci/pathway Function Predicted impact and change in growth capacity of knockout + triclosan
“Sub-MIC” block
Purine biosynthesis (purL, purH) Nucleic acid production Genes involved in production of nucleotides
Lipopolysaccharide biosynthesis
(waaCGLPUYZ, wbbHIJL, wzxB)
Barrier function Genes involved in biosynthesis of lipopolysaccharide protected in the presence of
triclosan
Methionine biosynthesis (metBL) Amino acid synthesis
Stress response (marR) Regulation of stress
response
Inactivation of marR, the repressor of marA that coordinates an efflux-based stress
response
“MIC and above” block
Stress response (soxR) Regulation of stress
response
Inactivation of soxR, the repressor of soxS that coordinates an efflux-based stress
response
Ribose uptake (rbsBK) Sugar import Inactivation of the importer selected by triclosan
MDR efflux pumps (acrAB, emrA) Transport Multidrug efflux pumps protected in the presence of triclosan
Stress response (rpoN) Regulation Inserts antisense of rpoN enriched in the presence of triclosan
Fatty acid biosynthesis ( fabBIZ) Membrane barrier Overexpression of fatty acid biosynthesis selected by triclosan exposure
Phospholipid recycling
(mlaBCDEF)
Membrane barrier Phospholipid recycling machinery protected in the presence of triclosan
Potassium import (trkAH) K+ importer Importer disrupted in the presence of triclosan
mRNA stability (pcnB) Transcription fidelity Inactivation of poly(A) polymerase selected by triclosan
Protein stability (lon, infB, rsmB) Translation fidelity Disruption of lon and rsmB; up-regulation of infB selected by triclosan




Here we have incorporated inducible control to an outward-
facing promoter integrated into the transposon sequence, provid-
ing improved control of the expression levels of adjacent genes.
This approach has also improved “signal to noise” and allowed
comparisons of induced and uninduced conditions to identify
genes in which expression changes contribute to conditional sur-
vival. The use of a single, inducible promoter rather than a suite of
transposons with promoters of different strengths helps avoid loss
of density owing to only a subset of each library carrying each pro-
moter. It also avoids any site-specific insertional biases that may
arise from the different sequences of a suite of different transpo-
sons. Additionally, it has proved a suitable approach to identify
where “knockdown” of expression of a gene can influence sur-
vival, which we show has identified previously unknown targets.
The technology thus enables rapid and simultaneous genome-
wide genotype to phenotype association determinations.
In addition, we have developed the “AlbaTraDIS” analysis
software suite, which performs the automated identification of sig-
nificant changes inmapped sequence reads that reflect the chang-
es in the different mutant numbers between growth conditions.
“AlbaTraDIS” identifies significant insertion sites in a context-
and gene-agnostic manner and then identifies those inserts likely
to inactivate genes or alter their expression. Comparisons across
diverse conditions allows commonalities and differences in re-
sponses to a stress to be easily identified, allowing analysis and in-
tegration of large numbers of data sets in an efficient manner.
We have used TraDIS-Xpress to study mechanisms of resis-
tance to triclosan across a wide range of drug concentrations.
The data revealed the known mechanisms of triclosan resistance
and allowedus to identify essential genes involved in triclosan sen-
sitivity (including the known primary target) based on expression
changes. These experiments validate the use of outward facing pro-
moters in the TraDIS-Xpress method and show that the
AlbaTraDIS software suite can identify inserts efficiently and pre-
dict impacts on gene expression in an automated manner.




Figure 3. Novel importers contributing to triclosan sensitivity. (A,B) Insert patterns indicating inactivation of trkAH is beneficial for survival in the presence
of triclosan. (C) Increase in insertions within the first part of rbsB in triclosan-exposed libraries. (D–F) Growth curves for BW25113 and isogenic mutants
grown in LB broth supplemented with 0.125 mg/L of triclosan. Mutants were replicated on multiple plates. Each line indicates the average from an indi-
vidual plate; independent plates are represented by symbols (triangles, circles, or squares; allowing comparison between themutant and parent from each




to be analyzed in conjunction and the relationships between
different stress conditions to be inferred (Fig. 2). By using this
approach, we were able for the first time to differentiate the
differential impacts of triclosan exposure at high and low con-
centrations. These data are summarized in Figure 6, showing
an integrated diagram highlighting the fundamental distinct
mechanisms of triclosan action and resistance revealed by
TraDIS-Xpress. Previous work with other antibiotics and E. coli
has identified hermetic effects in which different doses impacted
transcription of a set of genes differently (Mathieu et al. 2016).
Our data also find clear differences in responses between different
exposure conditions, although at a greater resolution and with
higher sensitivity. Analysis of the comparison between “strength”
of a TraDIS-Xpress score and resulting impact in growth kinetics
did not show a strong correlation. The experiment was sensitive
in identifying conditionally important genes, but the degree of ef-
fect was harder to predict with accuracy. This may not be surpris-
ing given the different nature of the experiments, with TraDIS
being in essence a very large competitive index experiment in
which small differences in fitness can be sensitively identified,
whereas the growth kinetics experiments we used measure the
ability of mutants to grow in isolation.
Triclosan has become endemic in modern life and has been
shown to impact microbes in the environment (Li et al. 2019).
Our work suggests diverse residual concentrations of triclosan
may result in very different selective pressures, and these findings
mayhelp inform the risk of the selection of unintended cross-resis-
tance to other drugs. There have been multiple reports suggesting
links between triclosan and antibiotic resistance. A recent paper
described a link between triclosan exposure and induction of levels
of ppGpp, which in turn result in up to 10,000-fold levels of
protection against bactericidal antibiotics (Westfall et al. 2019).
We saw no signal for spoT or relA (genes
implicated in increasing ppGpp levels
in that study). It may be that increasing
ppGpp levels is not itself protective
against triclosan or that “hard-wired”
mutations are not needed to allow a fully
protective response to occur after expo-
sure, and hence, we observed no altered
pattern of inserts at these loci in the pres-
ence of triclosan.
Multidrug efflux pumps are known
to influence triclosan sensitivity, and
the structural components of the pumps
themselves were not protected by ex-
posure to subinhibitory concentrations
of triclosan although derepression of
marA, which controls efflux expression,
was selected. At concentrations above
the MIC, the AcrAB efflux system be-
comes critically important, withmutants
identified that will lead to pump overex-
pression through induction of SoxS or in-
activation of acrR and protection of acrAB
itself. Similarly, inactivation of mprA
with consequent augmented transcrip-
tion of the emrAB efflux system was
also observed when exposed to concen-
trations of triclosan above the MIC.
Selection of mutants that overexpress
these regulators is a well-known route
tomultidrug resistance and suggests exposure to triclosan concen-




Figure 4. Impact of lon and pcnB on triclosan sensitivity. (A,B) Insert patterns indicating inactivation of
lon and pcnB is beneficial for survival in the presence of triclosan. The format of these genetic maps is as
described in Figure 1. (C,D) Growth curves for BW25113 and isogenic mutants grown in LB broth sup-
plemented with 0.125 mg/L of triclosan. Mutants were replicated on multiple plates. Each line indicates
the average from an individual plate; independent plates are represented by symbols (triangles, circles, or
squares; allowing comparison between the mutant and parent from each individual plate). Red lines in-
dicate BW25113; blue lines, mutants.
Figure 5. Altering expression of targets impacts triclosan sensitivity. The
coding sequences of selected genes were cloned into the pBAD30 expres-
sion vector under transcriptional control of the arabinose-inducible pro-
moter. This was to modify their expression and test the predicted impact
on triclosan sensitivity. Genes fabI, infB, marAB, and fabZ were cloned in
the forward orientation, allowing their up-regulation after induction (un-
der the green bar). In contrast, fabA, rpoN, pstA, and lacA were cloned in
the reverse direction, allowing inducible production of an antisense tran-
script and consequent repression of expression (under the red bar). The
lacA and pBAD30 vector alone constructs were included as negative con-
trols. Duplicate recombinants (Rec1, Rec2) for each gene were tested by
spotting cultures onto LB-agar (top), LB agar supplemented with 0.04
µg/mL triclosan (middle), or LB agar supplemented with 0.04 µg/mL triclo-
san and 0.5% arabinose. All recombinants grew without selection, and
none grew in the presence of triclosan without arabinose. With triclosan
and arabinose induction, the fabI, infB, and marAB recombinants consis-




One currently unclear aspect of triclosan’s activity relates to
how it enters the cell: Although it is well established that triclosan
crosses the outermembrane through porins, there is no current ev-
idence about how triclosan crosses the inner membrane. Recent
debate has highlighted the importance of transporters in the up-
take of many small molecules rather than lipid diffusion (Kell
and Oliver 2014). We identified two uptake systems (for ribose
and potassium) whose inactivation results in increased resistance
to triclosan. Specific mutants in these systems showed an in-
creased ability to grow in the presence of triclosan (Fig. 3), suggest-
ing they may have a role in drug import. Further work will be
needed to substantiate the role of these channels in triclosan
uptake.
The mechanism by which triclosan exerts a bactericidal
effect is also currently elusive. We observed a pattern of genes in-
volved in the protection of mRNA and protein stability, as well
as translation initiation as being involved in triclosan sensitivity
when exposed to high concentrations of the drug (Figs. 4, 6).
These observations suggest the cells’ central information process-
ing mechanism is compromised by high concentrations of triclo-
san. It remains to be seen if there is one or multiple secondary
targets for triclosan that confer the bactericidal effect at high
concentrations.
In this work, we show an improvement in transposon-based
functional genomics, reveal multiple new aspects of the mecha-
nisms of action and resistance of the canonical fatty acid biosyn-
thesis inhibitor triclosan, and use this information to assess how
differential exposure conditions impose distinct selective pres-
sures. The use of an inducible promoter allows the impacts of over-
expression and repression of all genes on phenotypes to be assayed
efficiently. The ability to compare different conditions rapidly and
to assay essential genes opens the door to high-throughput, ge-
nome-scale examination of bacterial responses to various stressors.
This approach can be applied to any
question in which the evaluation of bac-
terial fitness is important.
Methods
TraDIS-Xpress: a refined approach
allowing essential genes to be assayed for
roles in conditional survival
Although the original TraDIS protocol
has proved to be hugely powerful in as-
saying the role of the majority of genes
of any given bacteria in surviving any
given stress, essential genes cannot be as-
sayed owing to the lethality of any inser-
tions within them. To allow essential
genes to be assayed for roles in any given
stress, we included the use of an induc-
ible, outward facing promoter into the
transposon cassette. This allows con-
trolled induction of transcription from
the transposon insertion site: Inserts im-
mediately upstream of or downstream
from an essential gene will either up- or
down-regulate the gene. Changes in the
abundance of these inserts can therefore
be assayed by our new TraDIS-Xpress
protocol. To enable this approach, we in-
cluded an outward-oriented IPTG-induc-
ible tac promoter at the end of the kanamycin cassette, which
allows controlled induction of expression with IPTG in E. coli
(for controlled expression from the tac promoter in the transposon
cassette as assayed using a beta-galactosidase assay, see Supple-
mental Fig. S6). We used E. coli strain BW25113 as a model organ-
ism for these experiments as E. coli has been well studied for
triclosan mechanisms of action and resistance, is compatible
with the use of the tac promoter for conditional changes in gene
expression, and is the parent strain for the defined Keio-mutant
library, allowing access to independent inactivation mutants to
validate TraDIS predictions. Supplemental Table 3 shows all strains
and vectors used in this study.
Preparation of transposomes
Transposon Tnp001 is a mini-Tn5 transposon coding for kanamy-
cin resistance (aph(3′)-Ia) that incorporates an outward oriented,
IPTG-inducible tac promoter, 3′ to the kanamycin-resistance
gene. Transposon DNA was amplified by PCR using oligonucleo-
tides (primers are in Supplemental Table 4), and transposomes
were prepared by mixing purified transposon DNA with EZ-Tn5
transposase according to the supplier’s instructions (Lucigen).
The mixture was incubated for 1 h at 37°C and then stored at
−20°C before use.
Preparation of a BW25113-mutant library
E. coli strainBW25113wasprepared forelectroporationasprevious-
ly described (Doweret al. 1988). Bacteriawere grown in2×YTbroth
to an optical density of 0.3 (measured at 600 nm). After harvesting,
bacteria were washed three times in 10% glycerol before finally be-
ing suspended in 10% glycerol. Electrotransformations were per-
formed using a Bio-Rad “gene pulser II” electroporator set to 2400
Vand25µF, coupled toa “pulse controller II” set to 200Ω andusing
2-mm electrode gap cuvettes. Immediately after the electric pulse,
Figure 6. Overview of the major cellular pathways revealed as being involved in triclosan sensitivity by
TraDIS-Xpress. Proteins with blue name labels appear beneficial to survival in the presence of triclosan;
those with red name labels contribute to triclosan sensitivity. Dotted lines indicate potential routes of tri-




cellswere suspended in1mLof superoptimal brothwith catabolite
repression (S.O.C. medium; NEB) and incubated for 1 h at 37°C.
The cell suspension was then spread on LB agar supplemented
with kanamycin at 30 mg/L and incubated overnight at 37°C.
Resulting colonies were harvested and pooled together in 15%
glycerol in LB broth for storage at −70°C.
Triclosan exposure conditions
To determine the exposure conditions for experiments, the mini-
mum concentration of triclosan needed to inhibit growth of
BW25113 (MIC) was determined using a twofold dilutionmethod
in LBbroth, the same growthmedium thatwas used to perform the
TraDIS-Xpress experiments. In addition, viable countsof BW25113
were performed to determine bactericidal/bacteriostatic impacts
by preparing duplicate twofold serial dilutions of triclosan from
4 to 0.008 mg/L in LB broth, inoculated with ∼106 cfu/mL and in-
cubated at 37°C. Cell numbers at 0 h were obtained from a 10 µL
sample, removed immediately fromeach culture, and serially dilut-
ed 10-fold to a dilution of 10−7 in a 96-well plate. Five-microliter
volumes of the dilutions were then spotted onto LB-agar, and
the spots allowed to dry before incubation overnight at 37°C.
After the LB broth cultures plus triclosan dilutions had been incu-
bated for 24 h at 37°C, a second 10-µL sample was removed from
each and treated similarly to obtain viable counts after 24 h in
the presence of triclosan.
For TraDIS-Xpress experiments, approximately 107 mutants
from the transposon mutant library pool were grown in LB broth
supplemented with a range of concentrations of triclosan in dou-
bling increments ranging from0.008mg/L to 1mg/L, representing
a 125-fold range of concentrations. Experiments were also com-
pleted in the absence of IPTG or in the presence of either 0.2 or
1 mM IPTG to induce transcription from the transposon outward
oriented promoter. Control experiments were also performed in
the presence of two ethanol concentrations (ethanol was used to
dissolve triclosan). All experiments were performed in duplicate.
A total of 66 independent TraDIS-Xpress experiments were
completed.
Preparation of customized sequencing library
The pooled mutant mixtures were grown overnight in LB broth in
the various conditions outlined above. DNA was extracted using a
“quick-DNA” fungal/bacterial 96 kit extraction kit (Zymo
Research). A Nextera DNA library preparation kit (Illumina) was
used to prepare DNA fragments for nucleotide sequencing except
that Tnp-i5 oligonucleotides were used instead of i5 index primers,
and 28 PCR cycles were used (Hancock et al. 2017). The amplified
DNA fragment mixture was selected for a size range of 300 bp–500
bp and sequenced on a NextSeq 500 sequencing machine using a
NextSeq 500/550 high output v2 kit (75 cycles).
Bioinformatics
Sequence reads from FASTQ files generated from TraDIS sequenc-
ing were mapped to the BW25113 reference genome (CP009273)
(Grenier et al. 2014) and analyzed using the Bio-TraDIS (version
1.4.1) (Barquist et al. 2016) and AlbaTraDIS (version 0.0.5) (Page
et al. 2019) toolkits. Bio-TraDIS was used to align sequence reads
(using SMALT version 0.7.4) to the reference genome and to create
insertion plots. To identify gene essentiality for the different con-
ditions, genes that have very few or no insertions are identified.
Within the Bio-TraDIS toolkit (tradis_essentiality.R), a threshold
value for the number of insertions within essential genes is esti-
mated using the observed bimodal distribution of insertion sites
over genes when normalized for gene length (Langridge et al.
2009; Barquist et al. 2013). To compare the insertion patterns be-
tween different concentrations of triclosan (conditions) and in
media only (control), the AlbaTraDIS pipeline was used. As the
TraDIS-Xpress approach also provides data on the induction and
repression of genes, we were interested in changes in frequency
of insertion patterns, not only within genes but also in the regions
flanking the gene. A preferential increase of insertions oriented to-
ward the gene (5′ to 3′) in the upstream region is suggestive ofmod-
ulation of expression. A preferential increase of insertions in the
antisense direction of the coding region of a gene (3′ to 5′) in the
downstream region is suggestive of inhibition of gene expression
by production of an interfering RNA transcript. To identify these
patterns, the AlbaTraDIS toolkit (albaTraDIS script using -a flag
for use of annotation) calculates the number of “forward” and “re-
verse” insertions per gene and 198 bp upstream of and down-
stream from the gene (using annotation for CP009273) (Grenier
et al. 2014) for all genes in all conditions and control. Then the
number of sequence reads are modelled on a per-gene basis using
a negative binomial distribution and an adapted exact test as im-
plemented in edgeR (Robinson et al. 2010) followed by multiple
testing correction (Benjamini and Hochberg 1995), which is
used to identify significant differences (using default cut-offs of
q-value ≤0.05, logFC≥1, logCPM>8) in insertion frequency be-
tween each condition and control. The result is a comprehensive
comparison that predicts which genes are important under the
test stress as well as an indication if a change in expression of a
gene (either down- or up-regulated) has certain advantages for sur-
vival in the different concentrations of triclosan.
Mapping of insertion sites was visually inspected using
“Artemis,” which was used to capture images of selected areas of
the genomes of interest with insertions for figures. (Carver et al.
2012)
Validation experiments
A total of 78 mutants were selected from the Keio library of de-
fined mutants to validate predictions from the TraDIS-Xpress
data set (Baba et al. 2006). Thesewere selected to include genes rep-
resenting the major pathways identified as involved in triclosan
sensitivity, as well as a set of six randomly selected genes with
no predicted impact on triclosan sensitivity. The Keio library con-
tains two independent insertional inactivated mutants for each
gene, and both were used for each of the 78 targets. Two triclo-
san-resistant mutants were also included: a BW25113 mutant se-
lected after exposure to high level triclosan (as in Webber et al.
2008b) and L702, a previously characterized highly triclosan-resis-
tant mutant of Salmonella typhimurium (Webber et al. 2008b).
Both carried substitutions within FabI (Gly93Val).
For each mutant, the MIC of triclosan was determined as pre-
viously detailed. In addition, the ability of all mutants to grow in
the presence of three concentrations of triclosan (0.015, 0.125,
and 0.5 mg/L) were determined over 24 h and compared with
drug-free controls to allow for generic growth impacts to be iden-
tified. Experiments were run in 96-well format in 100 µL of LB
broth inoculated with ∼1000 cfu. Growth was assessed by measur-
ing absorbance of cultures at 600 nm every 60 min in a BMG
FLUOstar Omega plate reader. Each experiment was duplicated,
giving four data sets for each gene (two for each mutant allele;
each repeated independently). BW25113was included in all exper-
iments, giving a total of 34 separate measurements for growth of
the parent in each condition.
Estimation of fitness from growth curve data
Fitness of each strain was estimated by the ratio of the incremental




0mg/L and 0.015mg/L triclosan. This ratio was calculated for each
replication of each strain on each plate, leading to each growth
curve at 0.125 mg/L; hence, the fitness of each strain at 0.125
mg/L triclosan is summarized by a value between zero and one.
These ratios were then modelled by a generalized linear mixed
model, using the “beta” distributional family with a logistic link,
estimated using the brms (Bürkner 2018) package in R (R Core
Team 2019), which provides an interface to the Stan platform for
Bayesian inference (Carpenter et al. 2017). Zeros were avoided by
adding the smallest nonzero ratio across thewhole data set to every
other value. A fixed effect with five levels was included for the
group to which each genotype belonged (TraDIS-indicated genes,
importers, controls, BW25113, Salmonella-positive controls)
with separate crossed groups effects for odd and even mutations
nested within genes, plates, and an individual-level group effect
to account for overdispersion. Four chains with 5000 warm-up
and 5000 sampling iterations were used. Default priors were used
throughout. The fitness of each mutant compared with
BW25113 was then described by sampling from the posterior dis-
tribution of the effect of each mutant minus the effect of
BW25113. Coefficients correspond to the estimated effect of
each mutation on the ratio of growth in 0.125 mg/L triclosan to
growth under no triclosan, on the logistic (log-odds) scale.
Examining the impacts of directed alteration of gene expression
on triclosan sensitivity
To confirm predicted impacts of altering expression of target
genes, a selection of genes of interest were cloned into the
pBAD30 vector under control of an arabinose-inducible promoter
using EcoRI and Xbal restriction sites. These constructs were then
tested for their ability to grow in the presence of different concen-
trations of triclosan on agar and in broth, both in a range of arab-
inose concentrations to induce expression of the cloned genes.
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